Overview

A Clinical Trial of Infliximab for Childhood Uveitis

Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This project is designed to test the hypothesis that infliximab is clinically useful for patients with refractory childhood uveitis.
Phase:
Phase 4
Details
Lead Sponsor:
Xiaomin Zhang
Treatments:
Infliximab